The more things change, the more they stay the same. This old French saying seems to apply rather aptly to the situation faced by respiratory clinicians using inhaled therapy for their patients with obstructive lung disease. Since the development of the pressurized metered-dose inhaler (pMDI) in 1956, inhaled medication has become the standard of care for both asthma and chronic obstructive pul...
